Last week, the U.S. Department of Veterans Affairs and the Department of Defense announced the establishment of two joint consortia to research the diagnosis and treatment of post-traumatic stress disorder (PTSD) and mild traumatic brain injury (mTBI) over the next five years.
The new consortia, a $107 million investment, include the Consortium to Alleviate PTSD and Chronic Effects of Neurotrauma Consortium.
The Consortium to Alleviate PTSD, organized by the University of Texas Health Science Center – San Antonio, San Antonio Military Medical Center, and the Boston VA Medical Center, will work toward discovering possible biomarkers that may lead to effective diagnostic, prognostic, treatment, and rehabilitative strategies to treat acute PTSD and prevent chronic PTSD.
The Chronic Effects of Neurotrauma Consortium, which includes Virginia Commonwealth University, the Uniformed Services University of the Health Sciences, and the Richmond VA Medical Center, will study the causes of chronic effects of mTBI and common comorbidities in order to improve diagnostic and treatment options. A main component of the research will be understanding the relationship between mTBI and neurodegenerative diseases, such as Parkinson’s disease .
The consortia are part of the National Research Action Plan, issued by President Barack Obama as an executive order in 2012. Read the joint VA and DoD press release  for more information. Learn more about the National Research Action Plan in this fact sheet .
Date originally posted: August 23, 2013.